These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18028031)

  • 21. Metabolites in safety testing: metabolite identification strategies in discovery and development.
    Nedderman AN
    Biopharm Drug Dispos; 2009 May; 30(4):153-62. PubMed ID: 19544286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and culture of precision-cut organ slices from human and animal.
    Fisher RL; Vickers AE
    Xenobiotica; 2013 Jan; 43(1):8-14. PubMed ID: 23030812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
    De Buck SS; Mackie CE
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
    Zhang Q; Wang GJ
    Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The complexities inherent in attempts to decrease drug clearance by blocking sites of CYP-mediated metabolism.
    Fisher MB; Henne KR; Boer J
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):101-9. PubMed ID: 16445122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of drug metabolism and interactions on the basis of in vitro investigations.
    Pelkonen O; Turpeinen M; Uusitalo J; Rautio A; Raunio H
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):167-75. PubMed ID: 15733211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empirical validation of a rat in vitro organ slice model as a tool for in vivo clearance prediction.
    de Graaf IA; de Kanter R; de Jager MH; Camacho R; Langenkamp E; van de Kerkhof EG; Groothuis GM
    Drug Metab Dispos; 2006 Apr; 34(4):591-9. PubMed ID: 16415126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do Fukui function maxima relate to sites of metabolism? A critical case study.
    Beck ME
    J Chem Inf Model; 2005; 45(2):273-82. PubMed ID: 15807488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic viability and pharmaco-toxicological reactivity of cryopreserved human precision-cut renal cortical slices.
    Vittorelli A; Gauthier C; Michoudet C; Baverel G
    Toxicol In Vitro; 2004 Jun; 18(3):285-92. PubMed ID: 15046775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism.
    Muruganandan S; Sinal CJ
    Clin Pharmacol Ther; 2008 Jun; 83(6):818-28. PubMed ID: 18388875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon.
    De Kanter R; Monshouwer M; Draaisma AL; De Jager MH; de Graaf IA; Proost JH; Meijer DK; Groothuis GM
    Xenobiotica; 2004 Mar; 34(3):229-41. PubMed ID: 15204696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formed and preformed metabolites: facts and comparisons.
    Pang KS; Morris ME; Sun H
    J Pharm Pharmacol; 2008 Oct; 60(10):1247-75. PubMed ID: 18812018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
    Baillie TA
    Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma and tissue binding as determinants of drug body distribution. Possible applications to toxicological studies.
    Barre J; Urien S; Albengres E; Tillement JP
    Xenobiotica; 1988 Jan; 18 Suppl 1():15-20. PubMed ID: 3344588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biotransformation of drugs in human skin.
    Svensson CK
    Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precision-cut tissue slices: applications in pharmacology and toxicology.
    Parrish AR; Gandolfi AJ; Brendel K
    Life Sci; 1995; 57(21):1887-901. PubMed ID: 7475939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
    Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
    Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of drug distribution images from whole-body thin tissue sections obtained using desorption electrospray ionization tandem mass spectrometry and autoradiography.
    Kertesz V; Van Berkel GJ; Vavrek M; Koeplinger KA; Schneider BB; Covey TR
    Anal Chem; 2008 Jul; 80(13):5168-77. PubMed ID: 18481874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting drug-drug interactions from in vitro drug metabolism data: challenges and recent advances.
    Obach RS
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):81-9. PubMed ID: 19152216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of precision-cut rat liver slices for studies of xenobiotic metabolism and toxicity: comparison of the Krumdieck and Brendel tissue slicers.
    Price RJ; Ball SE; Renwick AB; Barton PT; Beamand JA; Lake BG
    Xenobiotica; 1998 Apr; 28(4):361-71. PubMed ID: 9604300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.